Virtuix Holdings Inc. 8K

Virtuix Holdings Inc. reported Q1 FY2027 results showing strong order and margin improvements but continued losses and higher leverage, while emphasizing growing defense, enterprise, and healthcare opportunities and planned acquisitions.

On August 20, 2026, Virtuix Holdings Inc. (NASDAQ: VTIX) furnished an earnings presentation for its first quarter of fiscal 2027 (quarter ended June 30, 2026), outlining a 72% year-over-year increase in new orders and gross margin expansion to 30% despite a 26% decline in net sales to $0.8 million, and highlighting ongoing operating losses, increased indebtedness and a move to a stockholders’ deficit, alongside strategic progress in defense training programs, enterprise deployments with partners such as Tesla and NASA, and healthcare initiatives with Sirica Therapeutics as management pursues acquisitions and growth across consumer, defense, enterprise, and therapeutic markets.

Filing Facts

CIK

1606242

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-092131

Alert Tier

6